Small cap
CIAN Agro revenue doubles to ₹2,287 crore as auditors flag gaps
Consolidated profit surged to ₹223 crore on the back of recent acquisitions, but statutory auditors have raised concerns over plant outages and accounting reconciliations.
Man Industries targets ₹5,500 cr revenue for FY27
The company issued fresh guidance alongside its audited FY26 results, projecting revenue growth to ₹5,000-5,500 crore with margins of 13-15%.
Krsnaa Diagnostics reports FY26 results with no new surprises
The company confirmed FY26 profit figures previously disclosed to the market. Revenue growth remains modest, and the tax demand remains a known issue.
CIAN Agro revenue doubles to ₹2,287 cr as acquisitions pay off
Consolidated net profit surged to ₹223 crore, though the auditor flagged a forced power plant outage and mounting statutory dues.
Orchid Pharma annual profit drops to ₹45.2 crore
The company reported a sharp decline in annual standalone profit as auditors flagged unaudited US subsidiaries in the consolidated results.
Cosmic CRF files audited FY26 results; no new data provided
The company confirmed its audited standalone and consolidated figures for the year ended March 31, 2026, which were previously disclosed.
Uniparts India files audited annual results. Nothing new.
The FY26 figures are identical to the preliminary results already disclosed. This is a procedural filing.
BGR Energy's net loss widens to ₹1,279.8 cr. Auditor flags going-concern risk.
FY26 losses deepened as finance costs on ₹4,500 cr in borrowings surged. The board is now preparing a rights issue to restructure its negative balance sheet.
Uniparts profit jumps 81% as margins widen to 14%
Standalone net profit hit ₹1,502 million on a 25% revenue rise, with operating margins improving from 9.5% to 14%. Consolidated profit grew 80%.
Man Industries posts ₹196 cr profit, enters FY27 with ₹3,000 cr order book
FY26 standalone profit jumped 43%, revenue grew 11%. The new order book equals 87% of last year's revenue.
BGR Energy's FY26 loss widens to ₹1,279.8 cr. Auditor flags going-concern.
The statutory auditor has flagged material uncertainty over the company's ability to continue. The board is doubling authorised capital to pursue a rights issue while insolvency proceedings are stayed.
Krsnaa Diagnostics posts FY26 profit of ₹102.7 cr but the numbers are stale
The audited results disclose no new information beyond what the exchange already has. A ₹62.7 crore tax demand remains unresolved.
Rane (Madras) Q4 call transcript adds nothing new
The May 18 transcript rehashes the earnings call summary already disclosed. No new financial data or guidance was presented.
Krsnaa's profit is up 24% but it's hiding a ₹63 crore tax demand.
Standalone net profit rose to ₹102.7 crore, but ₹25.9 crore of that was a one-off investment revaluation. Auditors also flagged a ₹62.7 crore tax claim.
Divgi says ₹10-12 cr/month in new export approvals is now in hand
The auto-components maker's investor presentation shows production green lights for parts targeting ₹10-12 crore in monthly revenue, beyond the results the market already digested.
Chemplast writes off ₹898 cr, posts ₹1,003 cr net loss
The PVC maker’s standalone loss for FY26 includes an impairment tied to its Cuddalore subsidiary. The board is now looking for a strategic overhaul.
Rane Holdings Q4 concall transcript adds no new information
The call's content was already summarized and digested by the market. This filing is a transcript with no new details.
Orchid Pharma profit falls 57% on higher costs; auditor flags US units
Standalone net profit for FY26 dropped to ₹45.2 crore from ₹106.5 crore, confirming a severe earnings slide first signaled in Q3.
Shree Refrigerations nets ₹21.40 crore as FY26 revenue jumps 55.5%
A tightened working capital cycle and HVAC investments helped profit grow by 64.7% year-on-year.
Chemplast posts ₹1,003 cr standalone loss on PVC import headwinds
The write-down on its Cuddalore subsidiary dominates the full-year books. The board is now exploring strategic reorganisation.
Gandhi Special Tubes to return ₹78 crore via share buyback
The company reported a 16.5% rise in annual profit to ₹68.4 crore and plans to retire 7.14% of its equity at ₹900 per share.
Pari Washington dumps two-thirds of India Motor Parts holding in one trade
A foreign portfolio investor exited 2.79% of the micro-cap's equity in a single, unannounced open-market block worth an estimated ₹39 crore.
Orchid Pharma's annual profit drops 57%, auditor flags US subsidiary issues
Full-year profit fell to ₹45.2 crore from ₹106.5 crore a year ago. The auditor gave a qualified opinion on consolidated accounts due to unaudited US subsidiaries.
Chemplast writes off ₹898 cr in Cuddalore Vinyls as PVC imports crush the subsidiary
A full-year loss of ₹1,003 cr on a standalone basis. The board formed a committee to explore M&A and reorganisation, and brought in a former SBI deputy MD.
Dishman's debt refi plan is the headline, not the earnings beat
Q4 revenue rose 19% to ₹851 crore and FY26 profit jumped to ₹97.4 crore, but the call's real news is a proposed ₹800 crore refinancing with the promoter at 4%.